PKM and cardiac hypertrophy: Pharmacological modulation of PKM2 via small molecules conferred cardioprotection by attenuating fibrosis in pathological hypertrophy models like isoproterenol (ISO)-induced cardiac hypertrophy and angiotensin-II mediated cardiac remodeling [94,95].